GENE ONLINE|News &
Opinion
Blog

2023-06-08|

Analysis of the Patent Industry for Treating Erectile Dysfunction (ED)

by CHINGCHENG-LAW
Share To
According to the epidemiological data, the prevalence of erectile dysfunction is estimated to be between 14% and 48%. In addition, due to male privacy and conservatism, the prevalence may be underestimated. In fact, the incidence of moderate to severe ED is 9% among men aged 40-44, while it exceeds 56% in men aged 65 and above.

This article aims to provide a brief analysis of the related patents for the common active pharmaceutical ingredient Sildenafil in the treatment of Erectile dysfunction.

It's free! Log in now to read

LOG IN SUBSCRIBE NOW
LATEST
Discrimination Leads to Rapid Aging, Science Shows the Detrimental Effects of this Act
2024-05-17
A New Study has Linked Treatment Resistant Depression to Body Mass Index
2024-05-16
AI Reveals Sex-Related Brain Differences and Precision Medicine Potential
2024-05-16
The EU Sustainability Directive’s Influence on Pharmaceutical Supply Chains
2024-05-15
New UC Berkeley Study Challenges Traditional Views on Lactate and Carbohydrate Metabolism
2024-05-15
First Person to Receive Transplanted Pig Kidney has Died
2024-05-13
Kexing Biopharm Facility Passes EU GMP Certification for Paclitaxel for Injection (Albumin Bound)
2024-05-10
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top